Zealand Pharma A/S (CPH:ZEAL)
359.80
+6.40 (1.81%)
Jun 27, 2025, 4:59 PM CET
Zealand Pharma Employees
Zealand Pharma had 335 employees as of December 31, 2024. The number of employees increased by 82 or 32.41% compared to the previous year.
Employees
335
Change (1Y)
82
Growth (1Y)
32.41%
Revenue / Employee
144.66K DKK
Profits / Employee
-3.08M DKK
Market Cap
25.54B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Novo Nordisk | 77,349 |
Coloplast | 16,639 |
Genmab | 2,682 |
Demant | 22,639 |
ALK-Abelló | 2,753 |
H. Lundbeck | 5,707 |
Ambu A/S | 5,196 |
GN Store Nord | 7,347 |
Zealand Pharma News
- 10 days ago - Zealand Pharma Obesity Therapy Shows Positive Trial Results - Market Watch
- 10 days ago - Zealand Pharma announces positive topline results from 28-week Phase 1b trial with GLP-1/GLP-2 receptor dual agonist dapiglutide - GlobeNewsWire
- 21 days ago - Zealand Pharma increases its share capital as a result of the exercise of employee warrants - GlobeNewsWire
- 26 days ago - Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome - GlobeNewsWire
- 4 weeks ago - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons - GlobeNewsWire
- 4 weeks ago - European stocks edge higher after Trump delays 50% tariffs on EU - CNBC
- 4 weeks ago - European stocks recover after Trump delays EU tariffs in hopes of deal - Reuters
- 5 weeks ago - Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer - GlobeNewsWire